Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242

1.

The 20th anniversary of IMAJ.

Shoenfeld Y, Shemer J, Keren G.

Isr Med Assoc J. 2019 Mar;21(3):141. No abstract available.

2.

The epidemiology and economic burden of hip fractures in Israel.

Barnea R, Weiss Y, Abadi-Korek I, Shemer J.

Isr J Health Policy Res. 2018 Aug 2;7(1):38. doi: 10.1186/s13584-018-0235-y.

3.

Examining the use of health systems and policy research in the health policymaking process in Israel: views of researchers.

Ellen ME, Lavis JN, Shemer J.

Health Res Policy Syst. 2016 Sep 1;14(1):66. doi: 10.1186/s12961-016-0139-7.

4.

[Professionalism in healthcare organizations--a unique model in the Assuta Medical Centers Network].

Shemer J, Abadi-Korek I.

Harefuah. 2015 Apr;154(4):259-62, 279, 278. Hebrew.

PMID:
26065223
5.

[80 years of public-private healthcare services in Assuta].

Abadi-Korek I, Shemer J.

Harefuah. 2015 Apr;154(4):221-3. Hebrew. No abstract available.

PMID:
26065213
6.

The Lancet strikes again.

Shoenfeld Y, Shemer J, Keren G, Eidelman L.

Isr Med Assoc J. 2014 Nov;16(11):738. No abstract available.

7.

Processes, contexts, and rationale for disinvestment: a protocol for a critical interpretive synthesis.

Wilson MG, Ellen ME, Lavis JN, Grimshaw JM, Moat KA, Shemer J, Sullivan T, Garner S, Goeree R, Grilli R, Peffer J, Samra K.

Syst Rev. 2014 Dec 11;3:143. doi: 10.1186/2046-4053-3-143.

8.

Health systems and policy research evidence in health policy making in Israel: what are researchers' practices in transferring knowledge to policy makers?

Ellen ME, Lavis JN, Sharon A, Shemer J.

Health Res Policy Syst. 2014 Dec 10;12:67. doi: 10.1186/1478-4505-12-67.

9.

Lancets unethical behavior.

Israeli E, Shemer J, Keren G, Shoenfeld Y.

Isr Med Assoc J. 2014 Aug;16(8):527-8. No abstract available.

10.

Personalized medicine and health economics: is small the new big? A white paper.

Abadi-Korek I, Glazer J, Granados A, Luxenburg O, Trusheim MR, Hakak N, Shemer J.

Isr Med Assoc J. 2013 Oct;15(10):602-7. No abstract available.

11.

Prostate cancer: do patients understand what they choose?

Abadi-Korek I, Shemer J.

Isr Med Assoc J. 2013 Mar;15(3):176-7. No abstract available.

12.
13.

[Peer Review].

Keren G, Shemer J, Shoenfeld Y.

Harefuah. 2012 Oct;151(10):600-2, 607. Hebrew. No abstract available.

PMID:
23316671
14.

Continuation of statin therapy and primary prevention of nonfatal cardiovascular events.

Shalev V, Goldshtein I, Porath A, Weitzman D, Shemer J, Chodick G.

Am J Cardiol. 2012 Dec 15;110(12):1779-86. doi: 10.1016/j.amjcard.2012.08.013. Epub 2012 Sep 25.

PMID:
23021514
15.

[Risk-sharing scheme in Israel--Kuvan as an allegory].

Abadi-Korek I, Shemer J.

Harefuah. 2012 Jun;151(6):362-3, 377, 376. Hebrew.

PMID:
22991868
16.

Quality of life and patient-perceived difficulties in the treatment of type 2 diabetes.

Tamir O, Wainstein J, Raz I, Shemer J, Heymann A.

Rev Diabet Stud. 2012 Spring;9(1):46-54. doi: 10.1900/RDS.2012.9.46. Epub 2012 May 10.

17.

[Medical resonance imaging (MRI)--the technology, the regulation and the utilization pattern in Israel].

Vaknin S, Shemer J, Luxenburg O.

Harefuah. 2012 May;151(5):306-9, 317. Hebrew.

PMID:
22844737
18.

The games go on: British Medical Journals play politics, again.

Shoenfeld Y, Shemer J, Keren G, Blachar Y, Eidelman L, Borow M.

Isr Med Assoc J. 2012 Feb;14(2):82-3. No abstract available. Erratum in: Isr Med Assoc J. 2012 Apr;14(4):270. Shoenfeld, Yehuda [added]; Shemer, Joshua [added]; Keren, Gad [added]; Blachar, Yoram [added]; Eidelman, Leonid [added]; Borow, Malke [added].

19.

Optimism of health care workers during a disaster: a review of the literature.

Boldor N, Bar-Dayan Y, Rosenbloom T, Shemer J, Bar-Dayan Y.

Emerg Health Threats J. 2012;5. doi: 10.3402/ehtj.v5i0.7270. Epub 2012 Jan 24.

20.

Response to health in the Occupied Palestinian Territory.

Ciechanover A, Shoenfeld Y, Shemer J, Eidelman L, Borow M.

Lancet. 2011 Oct 29;378(9802):e1; author reply e1. doi: 10.1016/S0140-6736(11)61667-X. No abstract available.

PMID:
22035555
21.

[Robot-assisted surgery--point of no return?].

Abadi-Korek I, Shemer J.

Harefuah. 2011 Sep;150(9):719-20, 751, 750. Hebrew.

PMID:
22026056
22.

[The search for medical information: the Israel Medical Association publishes update journals].

Shoenfeld Y, Keren G, Shemer J.

Harefuah. 2011 Sep;150(9):694-5. Hebrew. No abstract available.

PMID:
22026050
23.

The patient-perceived difficulty in diabetes treatment (PDDT) scale identifies barriers to care.

Tamir O, Wainstein J, Abadi-Korek I, Horowitz E, Shemer J.

Diabetes Metab Res Rev. 2012 Mar;28(3):246-51. doi: 10.1002/dmrr.1300.

PMID:
21990234
24.

[The future of medicine in Israel].

Shoenfeld Y, Shemer J, Keren G.

Harefuah. 2011 Aug;150(8):624. Hebrew. No abstract available.

PMID:
21939109
25.

[Personalized medicine--the future is already here].

Abadi-Korek I, Shemer J.

Harefuah. 2011 May;150(5):451-2, 490. Hebrew.

PMID:
21678641
26.

[Lifestyle modification--a behavioral and educational challenge].

Tamir O, Furmn-Assaf S, Shemer J.

Harefuah. 2010 Oct;149(10):650-1, 683. Hebrew.

PMID:
21568060
27.

[Counterfeit drugs in Israel and worldwide. Part II: distribution profile and anti-counterfeiting strategies and actions].

Furman-Assaf S, Tamir O, Marom E, Arieli M, Shemer J.

Harefuah. 2010 Jul;149(7):470-5, 479. Hebrew.

PMID:
21465764
28.

[Counterfeit drugs in Israel and worldwide. Part I: the extent of occurrence and impending threats].

Tamir O, Friedman N, Furman-Assaf S, Marom E, Arieli M, Shemer J.

Harefuah. 2010 Jul;149(7):466-9, 479. Hebrew.

PMID:
21465763
29.

[Over the counter drugs--a new era in Israel].

Abadi-Korek I, Vaknin S, Marom E, Shemer J, Luxenburg O.

Harefuah. 2011 Jan;150(1):29-32, 69, 68. Hebrew.

PMID:
21449153
30.

[The over the counter drugs reform in Israel--two years later].

Vaknin S, Abadi-Korek I, Marom E, Shemer J, Luxenburg O.

Harefuah. 2011 Jan;150(1):4-8, 70. Hebrew.

PMID:
21449147
31.

EQ-5D as a generic measure of health-related quality of life in Israel: reliability, validity and responsiveness.

Horowitz E, Abadi-Korek I, Shani M, Shemer J.

Isr Med Assoc J. 2010 Dec;12(12):715-20.

32.

Organisational efforts to improve quality while reducing healthcare disparities: the case of breast cancer screening among Arab women in Israel.

Wilf-Miron R, Galai N, Gabali A, Lewinhoff I, Tov OS, Lernau O, Shemer J.

Qual Saf Health Care. 2010 Oct;19(5):e36. doi: 10.1136/qshc.2008.029645. Epub 2010 Jun 17.

PMID:
20558476
33.

[Is it worthwhile to be a reviewer for a medical-scientific journal?].

Shoenfeld Y, Shemer J, Keren G.

Harefuah. 2009 Dec;148(12):824. Hebrew. No abstract available.

PMID:
20088435
34.

British medical journals play politics.

Shoenfeld Y, Shemer J, Keren G, Blachar Y, Eidelman LA, Borow M.

Isr Med Assoc J. 2009 Jun;11(6):325-7. No abstract available.

35.

[The 2009 outbreak of influenza A/H1N1: the world slows down].

Shemer J, Israeli E.

Harefuah. 2009 May;148(5):281-4. Hebrew. No abstract available.

PMID:
19630354
36.

Health technology management in Israel: HTA in action.

Shemer J, Shani M, Tamir O, Siebzehner MI.

Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:134-9. doi: 10.1017/S0266462309090540. Epub 2009 Jun 16.

PMID:
19527535
37.

[Laparascopic surgery and robotic-guided surgery].

Shemer J.

Harefuah. 2009 Mar;148(3):169-70, 210. Hebrew.

PMID:
19485275
38.

[Assessment of health related quality of life--part 3--preference based measures].

Horowitz E, Hassidim H, Abadi-Korek I, Shemer J.

Harefuah. 2008 Nov;147(11):914-9, 938. Hebrew.

PMID:
19264015
39.

A decade to the Israeli Center for Technology Assessment in Health Care.

Tamir O, Shemer J, Shani M, Vaknin S, Siebzehner MI.

Isr Med Assoc J. 2008 Dec;10(12):901-5. Review.

40.

[Assessment of health related quality of life--part 2--health state measures].

Horowitz E, Hassidim H, Abadi-Korek I, Shemer J.

Harefuah. 2008 Oct;147(10):820-4, 836. Hebrew.

PMID:
19039916
41.

[Assessment of health related quality of life--Part 1--Direct measures].

Horowitz E, Hassidim H, Abadi-Korek I, Shemer J.

Harefuah. 2008 Aug-Sep;147(8-9):731-4, 748. Hebrew.

PMID:
18935765
42.

[The crucial encounter between technology and medicine].

Siebzehner MI, Lavon E, Shemer J.

Harefuah. 2008 Jul;147(7):643-8, 660. Hebrew.

PMID:
18814527
43.
44.

[Economic evaluation of health technologies: theory and practice].

Abadi-Korek I, Shemer J.

Harefuah. 2008 Jun;147(6):509-11, 574. Hebrew.

PMID:
18693627
45.

Perspective: the case for subspecialty clinical learning in early medical education-moving from case-based to patient-based learning.

Seifan A, Kheck N, Shemer J.

Acad Med. 2008 May;83(5):438-43. doi: 10.1097/ACM.0b013e31816bed81.

PMID:
18448896
46.

Adoption of cost consciousness: attitudes, practices, and knowledge among Israeli physicians.

Wilf-Miron R, Uziel L, Aviram A, Carmeli A, Shani M, Shemer J.

Int J Technol Assess Health Care. 2008 Winter;24(1):45-51. doi: 10.1017/S0266462307080063.

PMID:
18218168
47.

[The need for a fifth faculty of medicine and where to locate it].

Shoenfeld Y, Eidelman L, Afek A, Birkenfeld S, Blachar Y, Shemer J.

Harefuah. 2007 Nov;146(11):818-20. Hebrew. No abstract available.

PMID:
18087821
48.

Deaths following influenza vaccination--background mortality or causal connection?

Kokia ES, Silverman BG, Green M, Kedem H, Guindy M, Shemer J.

Vaccine. 2007 Dec 12;25(51):8557-61. Epub 2007 Oct 29.

PMID:
18006121
49.

Impact of new medical technologies on health expenditures in Israel 2000-07.

Rabinovich M, Wood F, Shemer J.

Int J Technol Assess Health Care. 2007 Fall;23(4):443-8.

PMID:
17937832
50.

[Threshold values for cost-effectiveness ratio and public funding of medical technologies].

Rabinovich M, Greenberg D, Shemer J.

Harefuah. 2007 Jun;146(6):453-8, 500. Review. Hebrew.

PMID:
17760400

Supplemental Content

Loading ...
Support Center